TerminatedNCT00169949
Aripiprazole Treatment of the Prodrome
Medication studyAges 13–22United StatesSchizophrenia
Understand this study
Who could participate?
Listed age limits: 13 years to 22 years.
- Listed locations
- Glen OaksSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJanuary 2004
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 30
- Sponsor
- Northwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 13 Years to 22 Years
- Official registry ID
- NCT00169949
- Official title
Show the full official title
Open-Label Study of Aripiprazole in Individuals at Risk for Chronic Mental Illness
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Glen Oaks
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Northwell Health.
Does this study involve medication?
Yes. The study involves medication, including aripiprazole.
Who can participate?
Listed age limits: 13 years to 22 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)